Both OCT2 and MATE2-K transport and eliminate organic cationic drugs from the blood into the urine [28], including metformin, an oral hypoglycemic drug primarily used in the treatment of type-2 diabetes mellitus. This evidence concerns the gene SLC22A2 and type 2 diabetes mellitus.